Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.

  title={Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.},
  author={Frederic G Dhermain and Peter Hau and Heinrich Lanfermann and Andreas H. Jacobs and Martin J. van den Bent},
  journal={The Lancet. Neurology},
  volume={9 9},
Imaging techniques are important for accurate diagnosis and follow-up of patients with gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method. However, this technique only reflects biological activity of the tumour indirectly by detecting the breakdown of the blood-brain barrier. Therefore, especially for low-grade glioma or after treatment, T1-weighted MRI enhanced with gadolinium has substantial limitations. Development of more advanced imaging methods to improve… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
104 Citations
106 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 104 extracted citations


Publications referenced by this paper.
Showing 1-10 of 106 references

Diff usion restriction as a predictor of response in recurrent glioblastoma patients receiving bevacizumab

  • J Wu, MR Gilbert, JF DeGroot, WA Yung, VK Puduvali
  • J Clin Oncol
  • 2010

Use of perfusion MR imaging for diff erentiation between tumour progression and pseudo - progression in recurrent glioblastoma multiforme

  • C Heidemans-Hazelaar, AY Verbeek, HM Oosterkamp, CJ vanderKallen, CJ Vecht
  • Proc Am Soc Clin Oncol
  • 2010

Similar Papers

Loading similar papers…